Definium Therapeutics Inc. Common Shares vs FormFactor Inc. FormFactor Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while FormFactor Inc. FormFactor Inc. Common Stock trades at $139.44 (market cap $10.92B). The key difference: FormFactor Inc. FormFactor Inc. Common Stock is far larger — about 2.3× Definium Therapeutics Inc. Common Shares's market cap, and FormFactor Inc. FormFactor Inc. Common Stock is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and FormFactor Inc. FormFactor Inc. Common Stock for 0 Days on average.
| DFTX | FORM | |
|---|---|---|
Market Cap | $4.71B | $10.92B |
Volume | 1,966,636 | 1,056,924 |
Sector | Health | Technology |
52-Week High | $48.45 | $159.93 |
52-Week Low | $10.68 | $38.14 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $10.61B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →FormFactor, Inc. provides semiconductor test and measurement technologies used across the integrated circuit lifecycle, manufacturing probe cards and analytical probes through its Probe Cards segment and probe stations, thermal systems, and cryogenic systems through its Systems segment.
Read more on FORM →